Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label products under the Entero Surgicals private label, such as monitoring devices, nursing and rehabilitation products, and consumables; commercial solutions; and healthcare product distribution solutions, including imports, central warehousing, redistribution, last mile delivery, and connection with the pharmacies, hospitals, and clinics. The company was incorporated in 2018 and is based in Mumbai, India.
| Current Price | ₹1,498.90 |
|---|---|
| Market Cap | ₹6,898 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 57.1 |
| Return on Equity | 8.28% |
| 52-Week Range | ₹944.00 – ₹1,920.00 |
| Beta (1Y) | 0.09 |
| Revenue | ₹1,941 Cr |
|---|---|
| Net Profit | ₹52 Cr |
| EPS (Basic) | ₹8.77 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Trading of Pharmaceutical and Surgical Products-100%
Entero Healthcare Solutions Limited is trading at ₹1,498.90, with a market capitalisation of ₹6,898 Cr.
Entero Healthcare Solutions Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Entero Healthcare Solutions Limited has a P/E of 57.1 and a return on equity of 8.28%.
In Q1 FY27, Entero Healthcare Solutions Limited reported revenue of ₹1,941 Cr and net profit of ₹52 Cr, with basic EPS of ₹8.77 (consolidated, parsed from the company's exchange filing).